Joined SPM in 2022
International industry executive with extensive experience scaling and growing transformational companies. Recently, he helped scale Volpara Health resulting in its IPO on ASX, and also led R2 Technologies to a successful exit. Mark started his career at GE Healthcare where he held various leadership roles.
© 2023, ScreenPoint Medical BV. All rights reserved. Transpara® is a registered trademark of ScreenPoint Medical BV. Reproduction of any material contained herein in any format or media without express written permission of ScreenPoint Medical BV is prohibited. *Disclaimer: Transpara is CE marked and FDA cleared for 2D and 3D mammography. CE (0344) certified. FDA 510(k) K210404. Not all features are available in all countries. Please check with local representatives.
